Decellularized bovine intervertebral disc as a natural scaffold for xenogenic cell studies
Source abstract
Abstract
Low back pain that is associated with disc degeneration contributes to a huge economic burden in the worldwide healthcare system. Traditional methods, such as spinal fusion, have been adopted to relieve mechanical back pain, but this is compromised by decreased spinal motion. Tissue engineering has attracted much attention, and aims to correct the changes fundamentally occurring in the discs by a combination of cell biology, molecular biology and engineering. Synthetic materials including poly(l-lactic acid) or poly(glycolic acid) and biomolecules like hyaluronic acid or collagen have been adopted in the development of disc scaffolds for studying therapeutic approaches. Nevertheless, the complex biological and mechanical environment of the intervertebral disc (IVD) makes the synthesis of an artificial IVD with biomaterials a difficult task. Thus the aim of this study was to develop a natural disc scaffold for culturing disc cells for future development of biological disc constructs. We adopted a combination of currently used decellularization techniques to decellularize bovine IVD to create a complete endplate-to-endplate IVD scaffold. By altering the chemical and physical decellularization parameters, we reported the removal of up to 70% of the endogenous cells, and were able to preserve the glycosaminoglycan content, collagen fibril architecture and mechanical properties of the discs. The reintroduction of nucleus pulposus cells into the scaffold indicated a high survival rate over 7days, with cell penetration. We have shown here that conventional methods used for decellularizing thin tissues can also be applied to large organs, such as IVD. Our findings suggest the potential of using decellularized IVD as a scaffold for IVD bioengineering and culturing of cells in the context of the IVD niche.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Spine and Intervertebral Disc Pathology · Tissue Engineering and Regenerative Medicine · Musculoskeletal pain and rehabilitation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (65)
Show source-provided references
1. Degeneration of the intervertebral disc10.1186/ar629 ↗
2. Tissue-engineering approach to regenerating the intervertebral disc10.1089/ten.2005.0608 ↗
3. Stimulation of mature canine intervertebral disc by growth factors10.1097/00007632-199103000-00001 ↗
4. Osteogenic protein-1 is most effective in stimulating nucleus pulposus and annulus fibrosus cells to repair their matrix after chondroitinase ABC-induced in vitro chemonucleolysis10.1016/j.spinee.2004.11.001 ↗
5. Growth factor osteogenic protein-1: differing effects on cells from three distinct zones in the bovine intervertebral disc10.1097/01.PHM.0000130031.64343.59 ↗
6. Osteogenic protein-1 enhances matrix replenishment by intervertebral disc cells previously exposed to interleukin-110.1097/00007632-200206150-00014 ↗
7. Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications10.1016/S1529-9430(01)00021-3 ↗
8. Potential biologic therapies for the intervertebral disc
9. Disc chondrocyte transplantation in a canine model: a treatment for degenerated or damaged intervertebral disc10.1097/01.BRS.0000097891.63063.78 ↗
10. Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat10.1097/00007632-200208010-00007 ↗
11. Matrix turnover in human cartilage repair tissue in autologous chondrocyte implantation10.1002/1529-0131(200111)44:11<2586::AID-ART439>3.0.CO;2-I ↗
12. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells10.4049/jimmunol.176.5.2864 ↗
13. Mesenchymal stem cells avoid allogeneic rejection10.1186/1476-9255-2-8 ↗
14. Bone mesenchymal stem cells transplanted into rabbit intervertebral discs can increase proteoglycans10.1097/01.blo.0000146534.31120.cf ↗
15. Extracellular matrix in disc degeneration
16. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation10.1002/jbm.820270207 ↗
17. Biomimetic surface modification of poly(l-lactic acid) with gelatin and its effects on articular chondrocytes in vitro10.1002/jbm.a.10071 ↗
18. Novel approach to fabricate porous sponges of poly(d,l-lactic-co-glycolic acid) without the use of organic solvents10.1016/0142-9612(96)87284-X ↗
19. Decellularization of tissues and organs10.1016/j.biomaterials.2006.02.014 ↗
20. Decellularization of bovine corneas for tissue engineering applications10.1016/j.actbio.2009.02.011 ↗
21. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart10.1038/nm1684 ↗
22. Development and characterisation of a full-thickness acellular porcine bladder matrix for tissue engineering10.1016/j.biomaterials.2006.10.005 ↗
23. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves10.1016/j.jsb.2003.08.002 ↗
24. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix10.1038/nm.2170 ↗
25. Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded10.1089/ten.tea.2009.0659 ↗
26. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction10.1016/j.trim.2003.12.016 ↗
27. Porcine small intestinal submucosa (SIS): a bioscaffold supporting in vitro primary human epidermal cell differentiation and synthesis of basement membrane proteins10.1016/S0305-4179(00)00113-3 ↗
28. Characterization of a new tissue-engineered human skin equivalent with hair10.1007/s11626-999-0081-x ↗
29. Preparation of the acellular scaffold of the spinal cord and the study of biocompatibility10.1038/sc.2009.170 ↗
30. Development and characterization of an acellular porcine medial meniscus for use in tissue engineering10.1089/tea.2007.0233 ↗
31. Extraction techniques for the decellularization of tissue engineered articular cartilage constructs10.1016/j.biomaterials.2009.03.050 ↗
32. A mechanical evaluation of three decellularization methods in the design of a xenogeneic scaffold for tissue engineering the temporomandibular joint disc10.1016/j.actbio.2008.01.016 ↗
33. In vitro organ culture of the bovine intervertebral disc: effects of vertebral endplate and potential for mechanobiology studies10.1097/01.brs.0000201302.59050.72 ↗
34. Minimizing cryopreservation-induced loss of disc cell activity for storage of whole intervertebral discs10.22203/eCM.v019a26 ↗
35. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue10.1016/0304-4165(86)90306-5 ↗
36. Intradiscal injections of osteogenic protein-1 restore the viscoelastic properties of degenerated intervertebral discs10.1016/j.spinee.2006.04.014 ↗
37. The nature of viscoelastic behaviour
38. The proteoglycan contents of the temporomandibular joint disc influence its dynamic viscoelastic properties10.1002/jbm.a.10496 ↗
39. The artificial disc: theory, design and materials10.1016/0142-9612(96)84936-2 ↗
40. Biological treatment strategies for disc degeneration: potentials and shortcomings10.1007/s00586-006-0220-y ↗
41. Metabolism of the extracellular matrix formed by intervertebral disc cells cultured in alginate10.1097/00007632-199712150-00011 ↗
42. Collagen gene expression and mechanical properties of intervertebral disc cell–alginate cultures10.1016/S0736-0266(00)00003-6 ↗
43. The potential and limitations of a cell-seeded collagen/hyaluronan scaffold to engineer an intervertebral disc-like matrix10.1097/01.BRS.0000048672.34459.31 ↗
44. Intervertebral disc tissue engineering using a novel hyaluronic acid–nanofibrous scaffold (HANFS) amalgam10.1089/ten.tea.2008.0215 ↗
45. An atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) for the culture of annulus fibrosus cells from an intervertebral disc10.1002/jbm.a.10287 ↗
46. Cells from different regions of the intervertebral disc: effect of culture system on matrix expression and cell phenotype10.1097/00007632-200205150-00004 ↗
47. Collagen-based fibrous scaffold for spatial organization of encapsulated and seeded human mesenchymal stem cells10.1016/j.biomaterials.2008.11.003 ↗
48. Characterization of photocrosslinked alginate hydrogels for nucleus pulposus cell encapsulation10.1002/jbm.a.32191 ↗
49. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds10.1007/s00586-007-0443-6 ↗
50. Scaffolding in tissue engineering: general approaches and tissue-specific considerations10.1007/s00586-008-0745-3 ↗
51. Novel biodegradable poly(1,8-octanediol malate) for annulus fibrosus regeneration10.1002/mabi.200700053 ↗
52. ISSLS prize winner: integrating theoretical and experimental methods for functional tissue engineering of the annulus fibrosus10.1097/BRS.0b013e31818e61f7 ↗
53. Mechanical design criteria for intervertebral disc tissue engineering10.1016/j.jbiomech.2009.12.001 ↗
54. The use of coccygeal disc to study intervertebral disc metabolism10.1002/jor.1100110304 ↗
55. Tissue engineering with meniscus cells derived from surgical debris10.1016/j.joca.2008.08.001 ↗
56. Dynamic culture enhances stem cell infiltration and modulates extracellular matrix production on aligned electrospun nanofibrous scaffolds10.1016/j.actbio.2010.08.011 ↗
57. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells10.1016/j.jtcvs.2003.06.017 ↗
58. Damage of porcine aortic valve tissue caused by the surfactant sodiumdodecylsulphate10.1055/s-2007-1020381 ↗
59. In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions10.1016/j.biomaterials.2006.03.047 ↗
60. Intervertebral disc transplantation in the treatment of degenerative spine disease: a preliminary study10.1016/S0140-6736(07)60496-6 ↗
61. The alpha-gal epitope (Gal alpha 1–3Gal beta 1–4GlcNAc-R) in xenotransplantation10.1016/S0300-9084(01)01294-9 ↗
62. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation10.1172/JCI7358 ↗
63. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component10.1016/j.biomaterials.2008.11.040 ↗
64. Inhibition of the calcification of porcine valve tissue by selective lipid removal10.1016/0142-9612(94)90036-1 ↗
65. Autoimmunity and the clearance of dead cells10.1016/j.cell.2010.02.014 ↗